257 related articles for article (PubMed ID: 27036110)
21. Liver-Specific Overexpression of Prostasin Attenuates High-Fat Diet-Induced Metabolic Dysregulation in Mice.
Sekine T; Takizawa S; Uchimura K; Miyazaki A; Tsuchiya K
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361079
[TBL] [Abstract][Full Text] [Related]
22. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of testisin, a serine protease expressed by testicular germ cells, in epithelial ovarian tumor cells.
Shigemasa K; Underwood LJ; Beard J; Tanimoto H; Ohama K; Parmley TH; O'Brien TJ
J Soc Gynecol Investig; 2000; 7(6):358-62. PubMed ID: 11111072
[TBL] [Abstract][Full Text] [Related]
24. The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling.
Longuespée R; Boyon C; Castellier C; Jacquet A; Desmons A; Kerdraon O; Vinatier D; Fournier I; Day R; Salzet M
Histochem Cell Biol; 2012 Jul; 138(1):141-54. PubMed ID: 22532226
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer.
Chen LM; Hodge GB; Guarda LA; Welch JL; Greenberg NM; Chai KX
Prostate; 2001 Jul; 48(2):93-103. PubMed ID: 11433419
[TBL] [Abstract][Full Text] [Related]
27. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
28. Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin.
Friis S; Madsen DH; Bugge TH
J Biol Chem; 2016 Feb; 291(6):2577-82. PubMed ID: 26719335
[TBL] [Abstract][Full Text] [Related]
29. Mouse prostasin gene structure, promoter analysis, and restricted expression in lung and kidney.
Verghese GM; Tong ZY; Bhagwandin V; Caughey GH
Am J Respir Cell Mol Biol; 2004 Apr; 30(4):519-29. PubMed ID: 12959947
[TBL] [Abstract][Full Text] [Related]
30. Ibuprofen regulates the expression and function of membrane-associated serine proteases prostasin and matriptase.
Chai AC; Robinson AL; Chai KX; Chen LM
BMC Cancer; 2015 Dec; 15():1025. PubMed ID: 26715240
[TBL] [Abstract][Full Text] [Related]
31. [Prostasin (PRSS8) as a new pathological factor].
Uchimura K; Kitamura K
Nihon Rinsho; 2015 Mar; 73(3):523-33. PubMed ID: 25812384
[TBL] [Abstract][Full Text] [Related]
32. Validation of serum biomarkers for detection of early-stage ovarian cancer.
Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
[TBL] [Abstract][Full Text] [Related]
33. Significance of adding progesterone to the Risk of Ovarian Malignancy Algorithm for early stage ovarian cancer detection in patients with a pelvic mass: A single-center case-control study.
Pitynski K; Sporek A; Lipinska I; Banas T; Ludwin A; Bałajewicz-Nowak M
Taiwan J Obstet Gynecol; 2015 Dec; 54(6):766-72. PubMed ID: 26701000
[TBL] [Abstract][Full Text] [Related]
34. Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma.
Chen PX; Li QY; Yang Z
Ann Diagn Pathol; 2013 Oct; 17(5):425-9. PubMed ID: 23707658
[TBL] [Abstract][Full Text] [Related]
35. Potential markers that complement expression of CA125 in epithelial ovarian cancer.
Rosen DG; Wang L; Atkinson JN; Yu Y; Lu KH; Diamandis EP; Hellstrom I; Mok SC; Liu J; Bast RC
Gynecol Oncol; 2005 Nov; 99(2):267-77. PubMed ID: 16061277
[TBL] [Abstract][Full Text] [Related]
36. Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin.
Szabo R; Lantsman T; Peters DE; Bugge TH
Development; 2016 Aug; 143(15):2818-28. PubMed ID: 27385010
[TBL] [Abstract][Full Text] [Related]
37. Strong expression association between matriptase and its substrate prostasin in breast cancer.
Bergum C; Zoratti G; Boerner J; List K
J Cell Physiol; 2012 Apr; 227(4):1604-9. PubMed ID: 21678412
[TBL] [Abstract][Full Text] [Related]
38. Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers.
Takahashi S; Suzuki S; Inaguma S; Ikeda Y; Cho YM; Hayashi N; Inoue T; Sugimura Y; Nishiyama N; Fujita T; Chao J; Ushijima T; Shirai T
Prostate; 2003 Feb; 54(3):187-93. PubMed ID: 12518323
[TBL] [Abstract][Full Text] [Related]
39. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressor PRSS8 targets Sphk1/S1P/Stat3/Akt signaling in colorectal cancer.
Bao Y; Li K; Guo Y; Wang Q; Li Z; Yang Y; Chen Z; Wang J; Zhao W; Zhang H; Chen J; Dong H; Shen K; Diamond AM; Yang W
Oncotarget; 2016 May; 7(18):26780-92. PubMed ID: 27050145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
